Annual EBIT
-$8.69 M
-$19.20 K-0.22%
December 31, 2023
Summary
- As of February 12, 2025, QNRX annual earnings before interest & taxes is -$8.69 million, with the most recent change of -$19.20 thousand (-0.22%) on December 31, 2023.
- During the last 3 years, QNRX annual EBIT has fallen by -$6.64 million (-324.09%).
- QNRX annual EBIT is now -456.69% below its all-time high of -$1.56 million, reached on December 31, 2019.
Performance
QNRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.53 M
-$390.90 K-18.29%
September 30, 2024
Summary
- As of February 12, 2025, QNRX quarterly earnings before interest & taxes is -$2.53 million, with the most recent change of -$390.90 thousand (-18.29%) on September 30, 2024.
- Over the past year, QNRX quarterly EBIT has dropped by -$69.70 thousand (-2.84%).
- QNRX quarterly EBIT is now -670.50% below its all-time high of -$328.10 thousand, reached on September 30, 2020.
Performance
QNRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$8.65 M
-$402.80 K-4.88%
September 30, 2024
Summary
- As of February 12, 2025, QNRX TTM earnings before interest & taxes is -$8.65 million, with the most recent change of -$402.80 thousand (-4.88%) on September 30, 2024.
- Over the past year, QNRX TTM EBIT has dropped by -$279.80 thousand (-3.34%).
- QNRX TTM EBIT is now -2369.76% below its all-time high of -$350.20 thousand, reached on June 30, 2020.
Performance
QNRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
QNRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.2% | -2.8% | -3.3% |
| 3 y3 years | -324.1% | +8.9% | +11.4% |
| 5 y5 years | -456.7% | +8.9% | +11.4% |
QNRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.2% | +57.4% | -65.7% | +77.5% | -4.9% | +57.5% |
| 5 y | 5-year | -456.7% | +57.4% | -670.5% | +77.5% | -2369.8% | +57.5% |
| alltime | all time | -456.7% | +57.4% | -670.5% | +77.5% | -2369.8% | +57.5% |
Quoin Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.53 M(+18.3%) | -$8.65 M(+4.9%) |
| Jun 2024 | - | -$2.14 M(-13.1%) | -$8.25 M(-1.5%) |
| Mar 2024 | - | -$2.46 M(+61.1%) | -$8.37 M(-3.7%) |
| Dec 2023 | -$8.69 M(+0.2%) | -$1.53 M(-28.2%) | -$8.69 M(-5.2%) |
| Sep 2023 | - | -$2.13 M(-6.0%) | -$9.16 M(-2.0%) |
| Jun 2023 | - | -$2.26 M(-18.6%) | -$9.35 M(-4.2%) |
| Mar 2023 | - | -$2.78 M(+38.7%) | -$9.76 M(+6.5%) |
| Dec 2022 | -$8.67 M | -$2.00 M(-13.6%) | -$9.16 M(-50.2%) |
| Sep 2022 | - | -$2.32 M(-13.2%) | -$18.40 M(+6.7%) |
| Jun 2022 | - | -$2.67 M(+22.6%) | -$17.24 M(-7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.18 M(-80.6%) | -$18.71 M(-8.2%) |
| Dec 2021 | -$20.37 M(+894.6%) | - | - |
| Dec 2021 | - | -$11.24 M(+872.6%) | -$20.37 M(+101.7%) |
| Sep 2021 | - | -$1.16 M(-72.0%) | -$10.10 M(+8.9%) |
| Jun 2021 | - | -$4.13 M(+7.7%) | -$9.27 M(+69.0%) |
| Mar 2021 | - | -$3.84 M(+295.2%) | -$5.49 M(+232.7%) |
| Dec 2020 | -$2.05 M(+31.3%) | - | - |
| Dec 2020 | - | -$971.30 K(+196.0%) | -$1.65 M(+143.2%) |
| Sep 2020 | - | -$328.10 K(-6.3%) | -$678.30 K(+93.7%) |
| Jun 2020 | - | -$350.20 K | -$350.20 K |
| Dec 2019 | -$1.56 M | - | - |
FAQ
- What is Quoin Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals annual EBIT year-on-year change?
- What is Quoin Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals quarterly EBIT year-on-year change?
- What is Quoin Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals TTM EBIT year-on-year change?
What is Quoin Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of QNRX is -$8.69 M
What is the all time high annual EBIT for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high annual earnings before interest & taxes is -$1.56 M
What is Quoin Pharmaceuticals annual EBIT year-on-year change?
Over the past year, QNRX annual earnings before interest & taxes has changed by -$19.20 K (-0.22%)
What is Quoin Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of QNRX is -$2.53 M
What is the all time high quarterly EBIT for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$328.10 K
What is Quoin Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, QNRX quarterly earnings before interest & taxes has changed by -$69.70 K (-2.84%)
What is Quoin Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of QNRX is -$8.65 M
What is the all time high TTM EBIT for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high TTM earnings before interest & taxes is -$350.20 K
What is Quoin Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, QNRX TTM earnings before interest & taxes has changed by -$279.80 K (-3.34%)